Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/685
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Ketone doai > Benzene ring containing > Plural rings > C=o bonded directly to benzene ring
Description: Subject matter which contains a group directly bonded to a benzene ring.










Sub-classes under this class:

Class Number Class Name Patents
514/686 Two benzene rings bonded directly to the same c=o 39


Patents under this class:
1 2 3

Patent Number Title Of Patent Date Issued
8569382 Isolated compounds from Phaleria macrocarpa as anti-cancer agents Oct. 29, 2013
8568749 Systems and methods for skin rejuvenation Oct. 29, 2013
8563054 Anti-inflammatory agent Oct. 22, 2013
8470370 Controlled release formulations Jun. 25, 2013
8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jun. 11, 2013
8329220 Controlled release formulations Dec. 11, 2012
8282910 Composition for skin or hair Oct. 9, 2012
8263643 Polyphenol compounds with modulating neurotransmitter release Sep. 11, 2012
8252520 Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases Aug. 28, 2012
8236859 Use of 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl) propane-1-one for improved skin contouring or against cellulite Aug. 7, 2012
8119107 Photo-stable cosmetic or dermatological compositions Feb. 21, 2012
8106097 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jan. 31, 2012
7888365 Tri-aryl/heteroaromatic cannabinoids and use thereof Feb. 15, 2011
7872029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states Jan. 18, 2011
7799763 Muscle-strengthening drugs and anti-inflammatory drugs Sep. 21, 2010
7767719 Anthracenedione compounds Aug. 3, 2010
7749990 Compositions for the treatment of metabolic disorders Jul. 6, 2010
7745495 Pyridine ketones with herbicidal effect Jun. 29, 2010
7745424 Alkane diol derivatives as therapeutic agents for the treatment of bone conditions Jun. 29, 2010
7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Dec. 15, 2009
7598294 3,4-methylenedioxy-substituted chalcones as therapeutic agents Oct. 6, 2009
7326734 Treatment of bladder and urinary tract cancers Feb. 5, 2008
7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof Aug. 14, 2007
7101910 Compounds for the treatment of metabolic disorders Sep. 5, 2006
7056952 Isoflavone metabolites Jun. 6, 2006
7030162 Treatment of migraine headache Apr. 18, 2006
6984389 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Jan. 10, 2006
6916848 Compounds for the treatment of metabolic disorders Jul. 12, 2005
6906059 Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances Jun. 14, 2005
6858602 Compounds for the treatment of metabolic disorders Feb. 22, 2005
6828347 Anti-viral multi-quinone compounds and regiospecific synthesis thereof Dec. 7, 2004
6790463 Uses of targeted oxidative therapeutic formulation in arteriosclerosis Sep. 14, 2004
6774111 Carbohydrate system and a method for providing nutrition to a diabetic Aug. 10, 2004
6589997 Small-molecule modulators of hepatocyte growth factor/scatter factor activities Jul. 8, 2003
6462054 Inhibitors of fatty acid amide hydrolase Oct. 8, 2002
6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states Oct. 8, 2002
6455032 Composition and method for protecting skin from UV induced immunosuppression and skin damage Sep. 24, 2002
6416773 Cosmetic or dermatological light protection agent preparations Jul. 9, 2002
6413998 Compositions and methods for treating bone deficit conditions Jul. 2, 2002
6410587 Compounds and therapies for the prevention of vascular and non-vascular pathologies Jun. 25, 2002
6391921 Treatment of inflammation with 2,4,6-trihydroxy-.alpha.-para-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives May. 21, 2002
6346550 Hydroxylation activated prodrugs Feb. 12, 2002
6248790 Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives Jun. 19, 2001
6235773 Compositions for regulating skin appearance May. 22, 2001
6218435 Reduction of hair growth Apr. 17, 2001
6214886 Hydroxylation activated prodrugs Apr. 10, 2001
RE37087 Insecticidal triffluormethyl alkane derivatives Mar. 6, 2001
6187822 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase Feb. 13, 2001
6127422 Anti-viral method Oct. 3, 2000
6093408 Skin care compositions Jul. 25, 2000

1 2 3










 
 
  Recently Added Patents
Systems, computer programs, and methods for controlling costs of a healthcare practice
Randomly accessible visual information recording medium and recording method, and reproducing device and reproducing method
Surveillance apparatus and method for wireless mesh network
Non-phosphorus-based gellant for hydrocarbon fluids
Chemically resistant membranes, coatings and films and methods for their preparation
Delta-sigma AD converter circuit and battery pack
Reconstruction of deforming surfaces by canceling ambient occlusion and refining 3-D shape
  Randomly Featured Patents
Proximity sensor device and method with keyboard emulation
Pharmaceutically active compounds, preparation thereof, intermediates useful in such preparation and compositions containing the compounds
Ball circulating unit for linear ball guidance
Liquid filter
Compact ambidextrous locking mechanism
Front face of a wheel
Via structures and trench structures and dual damascene structures
Sensory simulator and editor and a method of using the same
Substituted N'-(arylcarbonyl)-benzhydrazides, N'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
System and method for verifying the connection status of couplable elements